Latham & Watkins advised CHEPLAPHARM on the offering. CHEPLAPHARM Arzneimittel GmbH announced the issuance of €750 million aggregate principal amount of New York law 144A/Reg S senior...
CHEPLAPHARM’s €750 Million High Yield Bond Offering
Grünenthal’s €300 Million Notes Offering
Latham & Watkins advised Grünenthal on the offering. Grünenthal GmbH announced the pricing of €300 million aggregate principal amount of 6.75% senior secured notes due 2030. The...
Atlantic Park and GIC’s €550 Million investment in Cheplapharm
Latham & Watkins has advised CHEPLAPHARM AG on the deal. CHEPLAPHARM AG (CHEPLAPHARM), a leading international platform for well-established branded medicines, announced its agreement for a...
Grünenthal’s €650 Million Bond Offering
Latham & Watkins LLP advised Grünenthal GmbH on the offering. Grünenthal GmbH executed the offering of a bond in two tranches with a total volume of...